about
Stem cells: An eventual treatment option for heart diseasesStem cell therapy and tissue engineering for correction of congenital heart diseaseAdult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivoTherapeutic Potential of Stem Cells Strategy for Cardiovascular DiseasesMicroRNA-363 negatively regulates the left ventricular determining transcription factor HAND1 in human embryonic stem cell-derived cardiomyocytes.Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.Morphological and functional changes in bone marrow mesenchymal stem cells in rats with heart failure.Transcriptional atlas of cardiogenesis maps congenital heart disease interactome.Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats.Stem cell therapy for pediatric dilated cardiomyopathy.Brain derived neurotrophic factor contributes to the cardiogenic potential of adult resident progenitor cells in failing murine heart.Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease.Model systems for cardiovascular regenerative biology.Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat.Clinical cardiac regenerative studies in childrenMyocardial regeneration of the failing heart.Pediatric systems medicine: evaluating needs and opportunities using congenital heart block as a case study.Cardiac regeneration: current therapies-future concepts.Hollow fibre membrane bioreactors for tissue engineering applications.An overview of the efficacy of resveratrol in the management of ischemic heart disease.Epicardium-Derived Heart Repair.Concurrent Isolation of 3 Distinct Cardiac Stem Cell Populations From a Single Human Heart Biopsy.Targeted MicroRNA Interference Promotes Postnatal Cardiac Cell Cycle Re-Entry.Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.Silk fibroin scaffolds enhance cell commitment of adult rat cardiac progenitor cells.Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells.Inhibitory effect of oxidative damage on cardiomyocyte differentiation from Wharton's jelly-derived mesenchymal stem cells.Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.Stem Cell Therapy and Congenital Heart Disease.Stem cells in pediatrics: state of the art and future perspectives.Mesenchymal stem cell in vitro labeling by hybrid fluorescent magnetic polymeric particles for application in cell tracking.Resveratrol and adipose-derived mesenchymal stem cells are effective in the prevention and treatment of doxorubicin cardiotoxicity in rats.Cardiac Telocytes in Regeneration of Myocardium After Myocardial Infarction.The Human Embryoid Body Cystic Core Exhibits Architectural Complexity Revealed by use of High Throughput Polymer Microarrays.
P2860
Q26782194-FAA0D3A4-D782-4050-9791-9FF8AFD9DA75Q26801514-19AF1DC6-52F0-47F1-9531-918D8A66AA0EQ27334044-11C639FB-A97E-4FD0-822D-3431DF868183Q28068965-C3905A87-B432-400B-9E59-1BA1297A0B0FQ33112695-730A0A0F-B50C-4271-BEF5-4C360055A76DQ33722466-A1929189-BC3C-4682-BDAC-3790AB9E09F1Q33744464-9E00FC87-EC5B-42C9-8B54-D088A09D5467Q33840353-4E395FFE-DE58-4B71-BF14-069C2D66E1FBQ33991604-656325DC-75ED-45B2-AE1E-B1FA12EA4707Q34026311-D2E6EF4C-8C28-4B70-8345-45147BC53B48Q35584104-0D96A86E-AE35-4D60-8BD2-E2A02EAE301BQ36142037-9D9FEA28-5617-4E21-8798-D596DAE9387FQ36933190-BC3D0D5A-C609-48AD-9E7D-7A2F3B128378Q37295332-6D1DEEBD-5567-47BC-BF22-AB26B66F7809Q37670955-9522D2CE-9080-4326-BCFD-A79800FB5046Q38045804-7EBCED2B-7248-41A6-B4BC-236DA0D8148CQ38078204-880EFD77-50EA-42AE-86D7-FCBC85C628E0Q38164335-67C8E320-034C-4B10-8805-2FD412BE5170Q38234214-4C14D1A1-E678-4FE5-AEA5-FB5F4F120766Q38557902-52A27127-916E-4851-BBFA-1A2DA4B5DE0DQ38930599-BCC24BC2-5AC9-4B21-A0A9-866441C438DDQ39265109-16AC8B2D-99C1-4DE9-A73F-CDA1F2153BE0Q40392149-CA5F3177-98C7-4F35-AC08-22691AAC44E4Q41018640-1BEAC423-2CC4-4339-8561-9E22194D464FQ41272675-3B2D7BC4-CAAF-4158-BE77-DFABF60D47A2Q42008825-026E3660-5A56-4379-9B98-326C7E19AEADQ42997205-57E39246-0DFC-44D0-9CE2-13159AF722A5Q47151522-2708CBD8-7758-4536-A7B4-E86CB2E1CC4EQ47848637-11871277-9019-4E2C-A266-CCE3F601E02FQ48083777-61BAABFC-C669-4E38-A19C-BD1C2F389846Q48607282-BE9681DD-8F03-4D8D-9D69-083D65D83A46Q48673712-81285BB9-907A-4B12-89EE-F033EA613407Q51276965-024BF682-2183-4C60-945C-B8B2FECACAA2Q51354259-3E13B6BC-B194-41A1-8F9B-D11ADE083A10Q53281892-F1A8C71D-77F9-4DB3-A3CF-A3477B5F2EA9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Stem cell therapy for cardiac disease.
@en
Stem cell therapy for cardiac disease.
@nl
type
label
Stem cell therapy for cardiac disease.
@en
Stem cell therapy for cardiac disease.
@nl
prefLabel
Stem cell therapy for cardiac disease.
@en
Stem cell therapy for cardiac disease.
@nl
P2860
P356
P1433
P1476
Stem cell therapy for cardiac disease.
@en
P2093
Deepak Srivastava
Harold S Bernstein
P2860
P2888
P304
P356
10.1038/PR.2011.61
P407
P433
P577
2012-02-08T00:00:00Z